Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard A Preston

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Statistical Methods in Medical Research|May 1, 2008
Recursive estimation method for predicting residual bladder urine volumes to improve accuracy of timed urine collectionsDavid Afshartous, Richard A Preston
American Journal of Therapeutics|March 12, 2003
Radiocontrast-induced nephropathyArif Asif, Richard A Preston, David Roth
Journal of the American Society of Hypertension : JASH|April 28, 2016
Hypertension in the frail elderlyBarry J Materson, Manuel Garcia-Estrada, Richard A Preston
American Journal of Therapeutics|March 16, 2005
Current trials of interventions to prevent radiocontrast-induced nephropathyArif Asif, Galo Garces, Richard A Preston, et al.
Clinical Pharmacokinetics|May 24, 2007
Pharmacokinetics and safety of ebastine in healthy subjects and patients with renal impairmentRobert J Noveck, Richard A Preston, Suzanne K Swan
American Journal of Therapeutics|June 22, 2010
Developing a safe intravenous sotalol dosing regimenJohn C Somberg, Richard A Preston, Vasant Ranade, et al.
Cardiology|August 10, 2010
QT prolongation and serum sotalol concentration are highly correlated following intravenous and oral sotalolJohn C Somberg, Richard A Preston, Vasant Ranade, et al.
Circulation|September 28, 2005
Antihypertensive effects of drospirenone with 17beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertensionWilliam B White, Bertram Pitt, Richard A Preston, et al.
American Journal of Therapeutics|January 14, 2014
The effect of renal and hepatic impairment on the pharmacokinetics of ospemifene, a tissue-selective estrogen agonist/antagonistRichard A Preston, Thomas C Marbury, Toshihiro Wajima, et al.
Journal of Clinical Pharmacology|July 3, 2002
Comparative effects on dynamic renal potassium excretion of ACE inhibition versus angiotensin receptor blockade in hypertensive patients with type II diabetes mellitusRichard A Preston, Neyton M Baltodano, Alberto B Alonso, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Statistical Methods in Medical Research|May 1, 2008
Recursive estimation method for predicting residual bladder urine volumes to improve accuracy of timed urine collectionsDavid Afshartous, Richard A Preston
American Journal of Therapeutics|March 12, 2003
Radiocontrast-induced nephropathyArif Asif, Richard A Preston, David Roth
Journal of the American Society of Hypertension : JASH|April 28, 2016
Hypertension in the frail elderlyBarry J Materson, Manuel Garcia-Estrada, Richard A Preston
American Journal of Therapeutics|March 16, 2005
Current trials of interventions to prevent radiocontrast-induced nephropathyArif Asif, Galo Garces, Richard A Preston, et al.
Clinical Pharmacokinetics|May 24, 2007
Pharmacokinetics and safety of ebastine in healthy subjects and patients with renal impairmentRobert J Noveck, Richard A Preston, Suzanne K Swan
American Journal of Therapeutics|June 22, 2010
Developing a safe intravenous sotalol dosing regimenJohn C Somberg, Richard A Preston, Vasant Ranade, et al.
Cardiology|August 10, 2010
QT prolongation and serum sotalol concentration are highly correlated following intravenous and oral sotalolJohn C Somberg, Richard A Preston, Vasant Ranade, et al.
Circulation|September 28, 2005
Antihypertensive effects of drospirenone with 17beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertensionWilliam B White, Bertram Pitt, Richard A Preston, et al.
American Journal of Therapeutics|January 14, 2014
The effect of renal and hepatic impairment on the pharmacokinetics of ospemifene, a tissue-selective estrogen agonist/antagonistRichard A Preston, Thomas C Marbury, Toshihiro Wajima, et al.
Journal of Clinical Pharmacology|July 3, 2002
Comparative effects on dynamic renal potassium excretion of ACE inhibition versus angiotensin receptor blockade in hypertensive patients with type II diabetes mellitusRichard A Preston, Neyton M Baltodano, Alberto B Alonso, et al.
Pageof 7